Medical benefit pharmaceutical policies for providers
See the latest updates to our medical benefit pharmaceutical policies.
G
MBP 113.0 Gazyva (obinutuzumab)
Gazyva (obinutuzumab) is a monoclonal antibody that targets CD20 antigen that is expressed on the surface pf pre-B and mature B-cell lymphocytes.
Reviewed 10/31/18
Related information
Learn more about Geisinger Health Plan.
Clinical guidelines
Clinical guidelines offer providers consistent and appropriate guidance for diagnosis and treatment of specific conditions or diseases.
Questions? Contact us
If you have questions or need more information, contact Geisinger Health Plan.